Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Down -28.45% in 4 Weeks, Here's Why You Should You Buy the Dip in Emergent Biosolutions (EBS)
11:02am, Thursday, 17'th Aug 2023
The heavy selling pressure might have exhausted for Emergent Biosolutions (EBS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree
Down -26.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Emergent Biosolutions (EBS)
10:59am, Wednesday, 16'th Aug 2023
The heavy selling pressure might have exhausted for Emergent Biosolutions (EBS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree
Emergent (EBS) Q2 Earnings Miss Estimates, Revenues Beat
10:42am, Wednesday, 09'th Aug 2023
Emergent (EBS) reports wider-than-expected second-quarter loss. The company lowered its 2023 guidance for some products and services.
Emergent Biosolutions (EBS) Reports Q2 Loss, Tops Revenue Estimates
09:11pm, Tuesday, 08'th Aug 2023
Emergent Biosolutions (EBS) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of $0.98. This compares to loss of $0.86 per share a year ago.
2023 Layoff Tracker: Tyson Foods, Emergent BioSolutions Cut Hundreds Of Jobs
04:38pm, Tuesday, 08'th Aug 2023
Layoffs continue apace after more than 136,000 employees were cut by major U.S. companies in the first quarter of 2023.
2023 Layoff Tracker: Emergent BioSolutions Cuts 400 Jobs
12:04pm, Tuesday, 08'th Aug 2023
Layoffs continue apace after more than 136,000 employees were cut by major U.S. companies in the first quarter of 2023.
Emergent BioSolutions to lay off about 400 employees
07:50am, Tuesday, 08'th Aug 2023
Emergent BioSolutions Inc said on Tuesday it plans to lay off about 400 employees across all businesses and cut back operations at some of its facilities.
Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023
06:30am, Tuesday, 25'th Jul 2023
GAITHERSBURG, Md., July 25, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 8, 2023, at 5:00 pm eastern time to discuss the financial res
Emergent's (EBS) Cyfendus Anthrax Vaccine Gets FDA Nod
10:42am, Friday, 21'st Jul 2023
Emergent's (EBS) shares rise as its anthrax vaccine, Cyfendus (AV7909), gets FDA approval, offering preventive measures for people aged 18 to 65, who were exposed to the harmful bacillus anthracis ger
US FDA approves Emergent BioSolutions' anthrax vaccine
06:20pm, Thursday, 20'th Jul 2023
Emergent BioSolutions said on Thursday the U.S. Food and Drug Administration has approved its anthrax vaccine.
Why Emergent BioSolutions Stock Dived by 9% Today
05:30pm, Tuesday, 27'th Jun 2023
The contract manufacturer announced a top-level executive transition. This transition is fairly sudden.
Better Recovery-Story Buy: Emergent BioSolutions or Invitae?
05:30am, Monday, 26'th Jun 2023
Emergent BioSolutions just got a nod from regulators for over-the-counter use of a product to fight opioid overdose. Invitae is making progress on a plan to reach positive cash flow.
Is Emergent BioSolutions Stock a Buy Now?
08:20am, Friday, 09'th Jun 2023
Emergent BioSolutions saw its stock plummet due to a bunch of problems in 2021. Its pipeline is unimpressive, and its services revenue isn't anything special.
Why Is Emergent Biosolutions (EBS) Down 21.4% Since Last Earnings Report?
12:38pm, Thursday, 08'th Jun 2023
Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock?
Down 75%, Can Emergent BioSolutions Turn Things Around?
08:20am, Wednesday, 07'th Jun 2023
Emergent BioSolutions' top line has been nosediving in recent quarters. The company's operations are also unprofitable, and the business is burning through cash.
